CJC-1295 + Ipamorelin 5mg+5mg

Details

CJC-1295 + Ipamorelin combines a GHRH analog with a selective growth hormone secretagogue, creating a complementary model for studying growth hormone pulse signaling and pituitary response. CJC-1295 is commonly evaluated for its sustained activity on the GH axis, while Ipamorelin is studied for targeted ghrelin-receptor activity. This blend is useful in research involving IGF-1 response, recovery pathways, lean-tissue models, sleep-related signaling, and endocrine rhythm analysis. Taken together, these characteristics position the material for structured studies where pathway-specific activity, comparative response, and consistency across experimental conditions matter.

Reconstitution

This vial contains 10 mg total active material: 5 mg CJC-1295 and 5 mg Ipamorelin. Add 2 mL of bacteriostatic water to create a solution containing 2.5 mg/mL of each peptide, or 5 mg/mL combined. On a U-100 syringe, 10 units equals 0.1 mL, which contains 0.25 mg of each peptide, or 0.5 mg combined.

Storage

Store lyophilized vials in a cool, dry, dark location until ready for laboratory use. Keep vials sealed and protected from moisture, direct light, and unnecessary temperature fluctuation. After reconstitution, store refrigerated unless your validated protocol specifies otherwise. Minimize repeated warming and cooling, avoid repeated freeze-thaw cycles, and label prepared vials with the preparation date and concentration.

Shipping

Orders are packed carefully before shipment. Fulfillment can take up to 5 business days depending on the product, order size, and current processing volume. After fulfillment, express shipping usually takes about 2 business days, though final carrier timing can vary by destination and service conditions. Tracking details are emailed once the order has been packed and fulfilled.